These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 33387037)
61. Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer. Trybek T; Walczyk A; Gąsior-Perczak D; Pałyga I; Mikina E; Kowalik A; Hińcza K; Kopczyński J; Chrapek M; Góźdź S; Kowalska A Endocrinology; 2019 Oct; 160(10):2328-2338. PubMed ID: 31305897 [TBL] [Abstract][Full Text] [Related]
62. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988 [TBL] [Abstract][Full Text] [Related]
63. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR. Zhang J; Yang Y; Zhao J; Shi L; Xu Y; Yu K; Guo C Pathol Res Pract; 2019 Apr; 215(4):761-765. PubMed ID: 30819583 [TBL] [Abstract][Full Text] [Related]
64. Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma. Lu Z; Zhang Y; Feng D; Sheng J; Yang W; Liu B Oncotarget; 2017 Jul; 8(28):45784-45792. PubMed ID: 28507274 [TBL] [Abstract][Full Text] [Related]
65. LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases. Pinheiro Dos Santos MJC; Bastos AU; da Costa VR; Delcelo R; Lindsey SC; Colozza-Gama GA; Peng H; Rauscher FJ; Oler G; Cerutti JM Endocr Pathol; 2018 Sep; 29(3):222-230. PubMed ID: 29560564 [TBL] [Abstract][Full Text] [Related]
66. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma. Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459 [TBL] [Abstract][Full Text] [Related]
67. BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases. Fakhruddin N; Jabbour M; Novy M; Tamim H; Bahmad H; Farhat F; Zaatari G; Aridi T; Kriegshauser G; Oberkanins C; Mahfouz R Sci Rep; 2017 Jul; 7(1):4666. PubMed ID: 28680105 [TBL] [Abstract][Full Text] [Related]
68. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma]. Jiang YY; Chen H; Xu BL; Wang S Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162 [No Abstract] [Full Text] [Related]
69. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338 [TBL] [Abstract][Full Text] [Related]
70. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321 [TBL] [Abstract][Full Text] [Related]
71. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. Elisei R; Viola D; Torregrossa L; Giannini R; Romei C; Ugolini C; Molinaro E; Agate L; Biagini A; Lupi C; Valerio L; Materazzi G; Miccoli P; Piaggi P; Pinchera A; Vitti P; Basolo F J Clin Endocrinol Metab; 2012 Dec; 97(12):4390-8. PubMed ID: 23066120 [TBL] [Abstract][Full Text] [Related]
72. Clinical Analysis of BRAF Dong SY; Chen J; Xia EJ; Lin RX; Du HY; Wang OC; Zhang XH; Hao RT Am Surg; 2020 May; 86(5):450-457. PubMed ID: 32684022 [TBL] [Abstract][Full Text] [Related]
73. RET Gene Fusions in Malignancies of the Thyroid and Other Tissues. Santoro M; Moccia M; Federico G; Carlomagno F Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32326537 [TBL] [Abstract][Full Text] [Related]
74. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]